Profil
Dean N.
DiMaria has been Senior Vice President of Nutrition 21, Inc. since November 9, 2006.
He joined Nutrition 21 in December 2005 as Vice President-Marketing, Sales and Communications.
From October 2004 to December 2005, Mr. DiMaria was Owner of the DMD Marketing and Sales Group.
From October 1995 to October 2004, he held various positions with Boehringer Ingelheim Pharmaceuticals, including General Manager of the Pharmaton Natural Health Products and Boehringer Ingelheim Consumer Healthcare Division.
Mr. DiMaria received a BS degree in Marketing from Western Michigan University.
Anciens postes connus de Dean N. DiMaria
Sociétés | Poste | Fin |
---|---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Corporate Officer/Principal | 08/09/2009 |
DMD Marketing | Corporate Officer/Principal | 01/12/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/10/2004 |
Formation de Dean N. DiMaria
Western Michigan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
DMD Marketing |